Clostridial myonecrosis in 21th century
Keywords:clostridial myonecrosis, evacuation, the use of a tourniquet, early diagnosis
AbstractThe emergence of a significant number of cases of Clostridial myonecrosis patients with war injuries requires a revision of the existing principles of early medical care, evacuation, early diagnosis and treatment of this disease.
Awad MM, Bryant AE, Stevens DL, Rood JI. Virulence studies on chromosomal alpha-toxin and theta-toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of alphatoxin in Clostridium perfringens-mediated gas gangrene. Mol Microbiol 1995; 15:191.
MACLENNAN JD. The histotoxic clostridial infections of man. Bacteriol Rev 1962; 6:177.
Wang Y, Lu B, Hao P, et al. Comprehensive treatment for gas gangrene of the limbs in earthquakes. Chin Med J (Engl) 2013; 126:3833.
Centers for Disease Control and Prevention (CDC). Update: Clostridium novyi and unexplained illness among injecting-drug users--Scotland, Ireland, and England, April-June 2000. MMWR Morb Mortal Wkly Rep 2000; 49:543.
Stevens DL, Laposky LL, McDonald P, Harris I. Spontaneous gas gangrene at a site of remote injury--localization due to circulating antitoxin. West J Med 1988; 148:204.
McNee JW, Dunn JS. The method of spread of gas gangrene into living muscle. Br Med J 1917; 1:727.
Robb-Smith AHT. Tissues changes induced by C. welchii type a filtrates. Lancet 1945; 2:362.
Williamson ED, Titball RW. A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangrene. Vaccine 1993; 11:1253.
Stevens DL, Titball RW, Jepson M, et al. Immunization with the C-Domain of alpha -Toxin prevents lethal infection, localizes tissue injury, and promotes host response to challenge with Clostridium perfringens. J Infect Dis 2004; 190:767.
Alouf JE, Geoffroy C. The Family of the Antigenically-Related, Cholesterol-Binding ("Sulphydryl-Activated") Cytolytic Toxins. In: Sourcebook of Bacterial Protein Toxins, Alouf JE, Freer JH (Eds), Academic Press, New York 1991. p.147.
Bryant AE, Bergstrom R, Zimmerman GA, et al. Clostridium perfringens invasiveness is enhanced by effects of theta toxin upon PMNL structure and function: the roles of leukocytotoxicity and expression of CD11/CD18 adherence glycoprotein. FEMS Immunol Med Microbiol 1993; 7:321.
Bryant AE, Stevens DL. Phospholipase C and perfringolysin O from Clostridium perfringens upregulate endothelial cell-leukocyte adherence molecule 1 and intercellular leukocyte adherence molecule 1 expression and induce interleukin-8 synthesis in cultured human umbilical vein endothelial cells. Infect Immun 1996; 64:358.
Copyright (c) 2018 Zdorov'a suspil'stva - Health of Society
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
- The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.